The department chief, Dr. Supakit Sirilak, said there is concernthat CH.1.1 might prove detrimental to the efficiency of the LAAB shots thatare used for those who have a compromised immune system, such as those withchronic kidney disease, cancer and organ transplant patients, the Bangkok Postreported.
He said that LAAB shots are still effective as a treatmentto enhance human immunity against the COVID-19.
The department is closely monitoring virus mutations andwill reduce complications in monitoring for virus mutations by using wholegenome sequencing every two weeks, instead of conducting the single nucleotidepolymorphism (SNP) genetic test for specified sub-variants./.